Pharmacological treatment of chronic stable angina pectoris
نویسندگان
چکیده
منابع مشابه
Stable Angina Pectoris
Background. Patients with chronic coronary artery disease exhibit a dysfunctioning endothelium, which may be responsible for exercise-induced platelet activation and expression of a procoagulant moiety. In this study, we evaluated the therapeutic efficacy of a low molecular weight heparin (Parnaparin) in patients with stable angina pectoris. Methods and Results. According to a double-blind, ran...
متن کاملTherapy of Stable Angina Pectoris
Case study: A 62-year-old male smoker with type 2 diabetes mellitus and hypertension presents with a 4-month history of exertional chest pain. Physical examination shows a blood pressure of 152/90 mm Hg but is otherwise unremarkable. The ECG is normal, and laboratory tests show a fasting blood glucose value of 110 mg/dL, glycosylated hemoglobin 6.0%, creatinine 1.1 mg/dL, total cholesterol 160,...
متن کاملManagement of stable angina pectoris
Stable angina pectoris is a common and disabling disorder. In recent years, its pathophysiology has been clarified and there have been major advances in its diagnosis and management. There is, however, no consensus as to the optimal strategy of investigation and treatment. Furthermore, its therapy has not been subjected to the same scrutiny by large randomized trials as has, for example, that o...
متن کاملEditorial Comment Medical Therapy of Chronic Stable Angina Pectoris
O ur understanding of chronic stable angina is gradually expanding, and two theories have developed in recent years. First, in patients with chronic stable angina, residual coronary flow reserve can be modulated to an important extent by dynamic changes in the caliber of pliable coronary artery stenoses with preserved muscular media.' This theory, coupled with the evidence of the remarkable eff...
متن کاملPlacebo in Patients With Chronic Stable Angina Pectoris
Background Ranolazine modulates the metabolism of ischemic myocardial cells and improves the efficiency of oxygen use. This study was conducted to evaluate the antianginal and anti-ischemic effects and safety of different doses of ranolazine administered three times daily (tid) compared with placebo in patients with stable angina pectoris. Methods and Results Patients with stable angina pectori...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Medicine
سال: 2013
ISSN: 1470-2118,1473-4893
DOI: 10.7861/clinmedicine.13-1-63